OVERALL GOAL
ENSURE THAT THE PEOPLE OF HAWAI ‘ I RECEIVE THE HIGHEST LEVEL OF CANCER CARE
BACKGROUND
• Clinical trials provide the highest level of quality of care for patients with cancer .
• The mortality rate from cancer is falling , in large part due to cancer research that has , through clinical trials , led to new and better methods of cancer prevention , detection and treatment .
• Children with cancer are enrolled onto clinical trials at a rate of 70-75 percent across the U . S .
• Only two percent of adults with cancer in the U . S . enroll on clinical trials .
CLINICAL TRIALS PROVIDE THE HIGHEST QUALITY OF CARE FOR CANCER PATIENTS
• Clinical trials provide closer supervision and monitoring than standard care .
• Patients always receive equal to or better than the standard of care .
• Patients have access to novel drugs , or new drug combinations , that may improve the response to treatment , increase the chance of cure and prolong survival .
WHY DO SO FEW ADULTS WITH CANCER PARTICIPATE IN CLINICAL TRIALS ?
• There is lack of awareness as to the value of clinical trials .
• Patients have medical concerns that they will receive less effective treatment than standard care .
• There is the fear of cancer , of the unknown and of dying .
• There are fnancial concerns about cost and insurance coverage .
• The lack of education and engagement of , and incentives for , oncology providers .
HAWAI ‘ I WILL BE THE ONLY STATE IN THE U . S . TO ACHIEVE THIS HIGH PROPORTION OF ENROLLMENT TO CLINICAL TRIALS .
20BY25
Initiative focused on :
• community education about cancer clinical trials ,
• engagement and training of oncology providers , and
• encouraging enrollment to cancer clinical trials .
ACHIEVE ENROLLMENT TO CANCER CLINICAL TRIALS OF 20 PERCENT OF ALL INDIVIDUALS WITH NEWLY DIAGNOSED AND RELAPSED CANCERS EACH YEAR BY 2025 .
• There are ~ 6,500 new cancer cases each year in Hawai ‘ i .
• The goal is to enroll 1,300 patients per year onto a cancer clinical trial .
• At least one-four th of these enrollments should be to treatment-based trials . Others may be to cancer prevention , supportive care , diagnostic and cancer healthcare delivery trials .
33